These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27181175)

  • 1. Aseptic meningitis after measles-mumps-rubella (MMR) vaccination.
    Mamishi S; Sarkardeh M; Pourakbari B; Keshavarz Valian S; Sabouni F; Mahmoudi S
    Br J Biomed Sci; 2016; 73(2):84-6. PubMed ID: 27181175
    [No Abstract]   [Full Text] [Related]  

  • 2. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom.
    Miller E; Andrews N; Stowe J; Grant A; Waight P; Taylor B
    Am J Epidemiol; 2007 Mar; 165(6):704-9. PubMed ID: 17204517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.
    da Cunha SS; Rodrigues LC; Barreto ML; Dourado I
    Vaccine; 2002 Jan; 20(7-8):1106-12. PubMed ID: 11803071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997.
    da Silveira CM; Kmetzsch CI; Mohrdieck R; Sperb AF; Prevots DR
    Int J Epidemiol; 2002 Oct; 31(5):978-82. PubMed ID: 12435771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is aseptic meningitis following mumps vaccination underreported in Japan?
    Uozumi Y; Miyahara M; Osaki K; Negoro M; Suga S
    Pediatr Int; 2022 Jan; 64(1):e14968. PubMed ID: 35189008
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project.
    Black S; Shinefield H; Ray P; Lewis E; Chen R; Glasser J; Hadler S; Hardy J; Rhodes P; Swint E; Davis R; Thompson R; Mullooly J; Marcy M; Vadheim C; Ward J; Rastogi S; Wise R
    Pediatr Infect Dis J; 1997 May; 16(5):500-3. PubMed ID: 9154545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of measles-mumps-rubella vaccine-associated aseptic meningitis in Germany.
    Schlipköter U; Mühlberger N; von Kries R; Weil J
    Infection; 2002 Dec; 30(6):351-5. PubMed ID: 12478324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.
    Dourado I; Cunha S; Teixeira MG; Farrington CP; Melo A; Lucena R; Barreto ML
    Am J Epidemiol; 2000 Mar; 151(5):524-30. PubMed ID: 10707922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children.
    Miller E; Goldacre M; Pugh S; Colville A; Farrington P; Flower A; Nash J; MacFarlane L; Tettmar R
    Lancet; 1993 Apr; 341(8851):979-82. PubMed ID: 8096942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine.
    Fujinaga T; Motegi Y; Tamura H; Kuroume T
    Pediatr Infect Dis J; 1991 Mar; 10(3):204-9. PubMed ID: 2041667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aseptic meningitis as a complication of mumps vaccination.
    Sugiura A; Yamada A
    Pediatr Infect Dis J; 1991 Mar; 10(3):209-13. PubMed ID: 2041668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aseptic meningitis after vaccination with L-Zagreb mumps strain-virologically confirmed cases. Faulty calculation of rates.
    Kaic B
    Vaccine; 2007 Jan; 25(7):1159-60. PubMed ID: 17092613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No demonstrable association between the Leningrad-Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt.
    Sharma HJ; Oun SA; Bakr SS; Kapre SV; Jadhav SS; Dhere RM; Bhardwaj S
    Clin Microbiol Infect; 2010 Apr; 16(4):347-52. PubMed ID: 20222892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical analysis of MMR vaccine adverse events on aseptic meningitis using the case cross-over design.
    Park T; Ki M; Yi SG
    Stat Med; 2004 Jun; 23(12):1871-83. PubMed ID: 15195321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: "Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design".
    Farrington CP
    Am J Epidemiol; 2004 Apr; 159(7):717-8; author reply 718-20. PubMed ID: 15033652
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurologic disorders after measles-mumps-rubella vaccination.
    Mäkelä A; Nuorti JP; Peltola H
    Pediatrics; 2002 Nov; 110(5):957-63. PubMed ID: 12415036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment to "Aseptic meningitis after vaccination with L-Zagreb mumps strain-virologically confirmed cases" faulty calculation of rates.
    Tesović G; Lesnikar V; Begovac J
    Vaccine; 2007 Jul; 25(28):5124-5. PubMed ID: 17555847
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia.
    Al-Mazrou Y; Tumsah S; Khalil M; Al-Jeffri M; Afzal MA; al-Ghamdy Y; Mishkhas A; Essa M
    J Trop Pediatr; 2002 Dec; 48(6):354-8. PubMed ID: 12521278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual trends in adverse events following mumps vaccination in Japan: A retrospective study.
    Ohfuji S; Tanaka T; Nakano T; Kase T; Kondo K; Fukushima W; Hirota Y
    Vaccine; 2022 Feb; 40(7):988-993. PubMed ID: 35058077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.
    Knutsson N; Jansson UB; Alm B
    Vaccine; 2006 Jul; 24(31-32):5800-5. PubMed ID: 16765490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.